Authorities in China arrested more than two dozen new suspects in their probe of a vaccine sales ring that has rocked the country since its discovery earlier…

Many people don't get the vaccines recommended by public health experts--and it's taking a toll on the U.S. economy. In fact, unvaccinated adults…

About 20 million people and one-third of children in the U.S. received AstraZeneca’s FluMist last year to protect against the seasonal virus, health officials…

While GlaxoSmithKline’s first-of-a-kind malaria vaccine, Mosquirix, is tied up with pilot projects, a competitor may be nearing in Sanaria’s PfSPZ.

HHS Secretary Sylvia Burwell has signed off on an $81 million fund allocation for federal agencies to continue research, though officials are stressing the…

On Monday, the New Jersey pharma announced its rVSV-ZEBOV has won the FDA’s Breakthrough Therapy Designation and the EMA’s Priority Medicines status.

Pfizer’s blockbuster vaccine Prevenar 13 will soon get a boost in a host of international markets. The shot won WHO backing in a new, easier-to-store…

With HPV rates on the rise in the U.K., researchers are pushing health authorities to include boys in an HPV vaccination program currently offered to females…

Already the world’s best-selling vaccine, Pfizer’s Prevnar 13 got yet another boost Tuesday with an expanded FDA approval in adults aged 18 to 49.

Regulatory